Activation of the kallikrein-kinin system in lung injury has long been recognized. However, the effects of bradykinin (BK) on human lung fibroblasts (HLF) remain to be elucidated. We determined whether BK stimulates HLF to release chemotactic activity for neutrophils and monocytes (NCA and MCA, respectively). We evaluated HLF supernatant fluids for chemotactic activity through a blind-well chamber technique. HLF released NCA and MCA in a dose-and time-dependent manner in response to BK. The release of chemotactic activity was inhibited by lipoxygenase inhibitors and cycloheximide. Molecular sieve column chromatography revealed that both NCA and MCA had multiple chemotactic peaks. NCA was inhibited by a leukotriene (LT) B 4 receptor antagonist and by antibodies to interleukin (IL)-8 and granulocyte colony-stimulating factor (G-CSF). MCA was attenuated by the LTB 4 receptor antagonist and by antibodies to monocyte chemoattractant protein-1 (MCP-1), granulocyte-macrophage colony-stimulating factor (GM-CSF), and transforming growth factor (TGF)-␤ . Both the LTB 4 receptor antagonist and these antibodies inhibited chemotactic activity of the molecular weights corresponding to MCP-1, GM-CSF, and TGF-␤ , separated by column chromatography. The concentrations of IL-8, G-CSF, MCP-1, GM-CSF, and TGF-␤ in supernatant fluids increased significantly in a time-dependent manner in response to BK. The receptors responsible for the release of NCA, MCA, and individual chemokines included both BKB 1 and BKB 2 receptors. These data suggest that BK may stimulate lung fibroblasts to release inflammatory cytokines, which may modulate lung inflammation. Koyama, S., E. Sato, H. Numanami, K. Kubo, S. Nagai, and T. Izumi. 2000. Bradykinin stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activity. Am. J. Respir. Cell Mol. Biol. 22:75-84.
Sequestration of peripheral blood neutrophils and monocytes within the lung is characteristic of a number of acute and chronic pulmonary diseases (1) (2) (3) (4) (5) . The presence of neutrophils is reflected by the local generation of chemotactic agents, which direct neutrophil migration from the vascular compartment into the alveolar space along chemotactic gradients. Additionally, alveolar macrophages (AM) are derived predominantly from differentiated peripheral blood monocytes, and to a limited extent from local macrophage replication (6) (7) (8) . Although chemotactically activated neutrophils and macrophages serve a vital role in host defense against a number of organisms, the presence of increased numbers of activated neutrophils and macrophages can lead to tissue injury through the excessive elaboration of inflammatory cytokines, proteolytic enzymes, and oxygen radicals (2, 9) . Substantial investigation has focused on AM as a primary source of chemotactic factors (10) (11) (12) . However, neutrophil chemotactic activity (NCA) and monocyte chemotactic activity (MCA) have been found to be produced by endothelial cells (13) , fibroblasts (14) , and pulmonary epithelial cells (15) (16) (17) .
The fibroblast is the principal cell of most connective tissues, and is involved in producing collagenous and noncollagenous components of the extracellular matrix. This synthetic activity serves an important structural function by providing a framework for organ integrity. Recent studies have shown that in addition to maintaining connective tissue, fibroblasts are also important participants in the orchestration of acute and chronic inflammation. In this context, fibroblasts release interleukin (IL)-8, monocyte chemoattractant protein-1 (MCP-1), granulocyte-macrophage colony-stimulating factor (GM-CSF), and transforming growth factor (TGF)-␤ in response to IL-1, tumor necrosis factor (TNF)-␣ , and platelet-derived growth factor, suggesting that they contribute to certain disease states (18) (19) (20) (21) (22) (23) (24) (25) .
Activation of the kallikrein-kinin system in lung injury has long been recognized. Bradykinin (BK) is generated from kininogens by the actions of plasma and tissue kallikreins (kininogenases) (26, 27) . The effects of BK on pulmonary circulation and lung mechanics have been intensively evaluated. BK also stimulates AM and airway epithelial cells to release chemotactic factors for inflammatory cells (28, 29) . Recently, a bradykinin B 2 (BKB 2 ) receptor antagonist was found to attenuate the acute lung injury induced by infusion of live Pseudomonas aeruginosa , including the migration of neutrophils into the lung and their sequestration in the lung (30) . In this context, BK may participate in the release of inflammatory mediators from lung cells.
Although airway epithelial cells and AM may play a role in inflammatory cell migration from the interstitium to the alveolar and bronchial spaces in response to BK (28, 29) , the mechanism underlying inflammatory cell migration from the vascular compartment to the interstitium remains to be elucidated. The role of human lung fibroblasts (HLF) in inflammatory cell recruitment from the vascular compartment to the interstitium in response to BK is uncertain. The purpose of the present study was to determine whether lung fibroblasts could participate in the recruitment of inflammatory cells to the lung interstitium. Specifically, we evaluated the possibility that lung fibroblasts release NCA and MCA in response to BK. The results showed that HLF can release NCA and MCA in response to BK, including leukotriene B 4 (LTB 4 ), IL-8, granulocyte colony-stimulating factor (G-CSF), MCP-1, GM-CSF, and TGF-␤ .
Materials and Methods

Culture of Human Lung Fibroblasts
We used fetal HLF (lung, diploid, human, passage 27) from an established, commercially available cell line (American Type Tissue Culture Collection, Rockville, MD). HLF were suspended at 1.0 ϫ 10 6 cells/ml in F-12 medium (GIBCO, Grand Island, NY) supplemented with penicillin (50 U/ ml; GIBCO), streptomycin (50 g/ml; GIBCO), fungizone (2 g/ml; GIBCO), and 10% fetal calf serum (GIBCO). HLF suspensions (3 ml) were added to 30-mm-diameter tissue culture dishes (Corning, Corning, NY) and were cultured at 37 Њ C in a 5% CO 2 atmosphere. After 4-6 d in culture, the cells had reached confluence, and the culture medium was then replaced with 2 ml of medium supplemented as described earlier and the cells were incubated for 1 d more.
Measurement of BK Concentrations in HLF Cultures
We measured the concentrations of BK at selected time points (12, 24, 48 , and 72 h) to evaluate the half-life and duration of the stimulating potential of BK after exposure of fibroblasts to HLF. BK was measured with a highly sensitive radioimmunoassay (RIA) as previously described (30) .
Exposure of HLF to BK
Medium was removed from cells by washing twice with serum-free F-12, and cells were then incubated in the presence and absence of BK (Sigma, St. Louis, MO). To determine the dose-and time-dependent release of NCA and MCA, the cultures were incubated at various concentrations of BK (0.01, 0.1, 1.0, 10, and 100 M) for 12, 24, 48, 72, and 96 h at 37 Њ C in a humidified 5% CO 2 atmosphere. BK at 100 M did not cause HLF injury (no deformity of cell shape or detachment from the tissue culture dish, and viability of more than 95% of cells by trypan blue dye exclusion) after 96 h of incubation. The supernatant fluids were then harvested and stored at Ϫ 80 Њ C until assayed. At least six separate HLF supernatant fluids were harvested for each experimental condition.
Measurement of NCA and MCA Polymorphonuclear leukocytes were purified from heparinized normal human blood by the method of Boyum (31) . Briefly, 15 ml of venous blood was obtained from healthy volunteers and was then sedimented with 3% dextran in isotonic saline for 45 min in order to separate the white blood cells from red blood cells. The leukocyte-rich upper layer was collected, and neutrophils were separated from mononuclear cells by Ficoll-Hypaque density centrifugation (Histopaque 1077; Sigma). Contaminating red blood cells were removed by using a lysing solution consisting of 0.1% KHCO 3 and 0.83% NH 4 Cl. The suspension was then centrifuged at 400 ϫ g for 5 min and washed three times in Hanks' balanced salt solution (HBSS; Biofluids, Rockville, MD). The resulting cell pellet, as determined by trypan blue dye and erythrosin exclusion, consisted of Ͼ 96% neutrophils and Ͼ 98% viable cells. The cells were suspended in Gey's balanced salt solution (GBSS; GIBCO) containing 2% bovine serum albumin (BSA; Sigma) at pH 7.2 to give a final concentration of 3.0 ϫ 10 6 cells/ml. This suspension was used for the neutrophil chemotaxis assay.
Mononuclear cells for the chemotaxis assay were obtained from normal human volunteers by Ficoll-Hypaque density centrifugation to separate red blood cells and neutrophils from mononuclear cells. The mononuclear cells were harvested at the interface. The suspension was then centrifuged at 400 ϫ g for 10 min and washed three times in HBSS. The resulting preparation routinely consisted of 30% large monocytes and 70% small lymphocytes as determined morphologically and by ␣ -naphthyl acetate esterase staining (Sigma), with Ͼ 98% viability as assessed by trypan blue dye and erythrosin exclusion. The cells were suspended in GBSS containing 2% BSA at pH 7.2 to give a final concentration of 5.0 ϫ 10 6 cells/ml. This suspension was then used for the monocyte chemotaxis assay.
The chemotaxis assay was performed in a 48-well microchemotaxis chamber (NeuroProbe Inc., Cabin John, MD) as previously described (32) . The bottom wells of the chamber were filled with 25 l of fluid containing the chemotactic stimulus or medium in duplicate. A 10-mthick polyvinylpyrrolidone-free polycarbonate filter (Nucleopore, Pleasanton, CA), with a pore size of 3 m for neutrophil chemotaxis and 5 m for monocyte chemotaxis, was placed over the bottom wells. The silicon gasket and upper pieces of the chamber were applied, and 50 l of the cell suspension was placed into the upper wells above the filter. The chambers were incubated in humidified air in 5% CO 2 at 37 Њ C for 30 min for neutrophil chemotaxis and for 90 min for monocyte chemotaxis. After incubation, the chamber was disassembled and cells that had not migrated were wiped away from the filter. The filter was then immersed in methanol for 5 min, stained with Diff-Quik (American Scientific Products, McGaw Park, IL), and mounted on a glass slide. Cells that had completely migrated through the filter were counted in 10 random high-power fields (hpf, magnification ϫ 1,000) per well by light microscopy.
To ensure that monocytes and not lymphocytes were the primary cells that migrated in the monocyte chemotaxis assay, some membranes were stained with ␣ -naphthyl acetate esterase according to the manufacturer's directions (Sigma).
To determine whether migration was due to movement along a concentration gradient (chemotaxis) or to stimulation of random migration (chemokinesis), a checkerboard analysis was done with HLF supernatant fluids harvested at 72 h in response to 100 M BK (33) . To do this, various dilutions of HLF supernatant fluids (1:1, 1:4, 1:16, 1:64, 1:256) were placed below the membrane of the microchemotaxis chamber and the target cells were placed above the membrane.
Molecular Sieve Column Chromatography of Chemotactic Activity
To determine the approximate molecular weight of the released chemotactic activity in the supernatant fluids harvested at 72 h in response to 100 M BK, we performed molecular sieve column chromatography, using Sephadex G-100 (Pharmacia, Piscataway, NJ). The supernatant fluid was not concentrated for passage through the column. The column size was 10 mm ϫ 900 mm. The bet volume was almost 60 ml. We put 2 ml of supernatant fluid into the column. HLF culture supernatant fluid was eluted with phosphate-buffered saline at a flow rate of 6 ml/h, and fractions after the void volume were evaluated in duplicate for NCA and MCA. The chemotactic activity might have been diluted by column chromatography; however, we collected 1 ml per fraction. Because peaks usually consisted of five to seven fractions (i.e., 5 to 7 ml), the chemotactic activity of each molecular-weight peak was not extensively diluted.
Effects of Metabolic Inhibitors on the Release of NCA and MCA
The effects of the nonspecific lipoxygenase inhibitors nordihydroguaiaretic acid (NDGA; 100 M; Sigma) and diethylcarbamazine (DEC; 1 mM; Sigma), and of the 5-lipoxygenase inhibitor AA-861 (100 M; Takeda Pharmaceutical Co., Tokyo, Japan) on the release of NCA and MCA were evaluated in response to 100 M BK after 72 h incubation. To further examine the involvement of protein synthesis in the release of chemotactic activity, we added cycloheximide (10 g/ml; Sigma) to inhibit protein synthesis (34) . At the concentrations used, NDGA, DEC, and AA-861 inhibited the release of LTB 4 in HLF cultures, and did not cause cytotoxicity to HLF after 72 h incubation.
Identification of Target BK Receptor on HLF
To determine the receptor responsible for the release of chemotactic activity, the BKB 1 receptor antagonist Des- 
Effects of LTB 4 and Platelet-Activating Factor Receptor
Antagonists on NCA and MCA Because the release of both NCA and MCA was blocked by 5-lipoxygenase inhibitors, and because both NCA and MCA were extracted into ethyl acetate, an LTB 4 receptor antagonist (ONO 4057; ONO Pharmaceutical Co., Tokyo, Japan) and a platelet-activating factor (PAF) receptor antagonist (TCV-409; Takeda), at a concentration of 10 Ϫ 5 M in each case, were used to evaluate the involvement of LTB 4 in NCA and MCA in the crude supernatant fluids and in the fraction of the lowest molecular mass separated by column chromatography (35, 36) .
Measurement of LTB 4 and PAF in Supernatant Fluids
The concentration of LTB 4 in the supernatant fluids was measured with an RIA as previously described (37) . Anti-LTB 4 serum, [5, 6, 8, 9, 11, 12, 14, 15, 3 H (N)]-LTB 4 , and synthetic LTB 4 were purchased from Amersham Inc. (Arlington Heights, IL). Briefly, ethanol-and-supernatant mixtures were centrifuged at 5,500 ϫ g at 0 Њ C. The supernatants were then evaporated under N 2 gas at 37 Њ C to remove the ethanol. To each sample, 10 ml of distilled water was added. The diluted samples were then acidified to pH 4.0 with 0.1 N HCl and were applied to Sep-Pak C18 columns (Waters Associates, Milford, MA). The columns were washed with a mixture of 10 ml of distilled water and 20 ml of petroleum ether, and were then eluted with 15 ml of methanol. The eluates were dried with N 2 gas at 37 Њ C and then redissolved in 20 l of methanol and 180 l of RIA buffer (50 mM Tris-HCl buffer containing 0.1% [wt/vol] gelatin, pH 8.6). [ 3 H]LTB 4 was diluted in RIA buffer (0.1 ml, containing approximately 4,000 dpm) and mixed with 0.1 ml of standards or samples in disposable siliconized tubes. Anti-LTB 4 serum, diluted with RIA buffer (0.1 ml), was added to the siliconized tubes to give a total incubation volume of 0.4 ml. The resulting mixture was incubated at 4 Њ C for 18 h. Free LTB 4 was absorbed onto dextrancoated charcoal. Following centrifugation for 15 min at 2,000 ϫ g , the supernatant containing the antibody-bound LTB 4 was decanted into the well of a scintillation counter (Tricarb-3255; Packard Co., Downers Grove, IL). Scintillation fluid (Aquazol 2; NEN Co., Boston, MA) was added, and radioactivity was counted for 4 min.
PAF in the supernatant fluids was quantitated with the scintillation proximity assay system. Briefly, this assay system combines the use of a tritiated PAF tracer of high specific activity with an antibody specific for PAF and a PAF standard similar to that used in the method for measuring LTB 4 .
Effects of Polyclonal Antibodies to IL-8, G-CSF, MCP-1, GM-CSF, TGF-␤ , and Regulated on Activation, Normal T-cell Expressed and Secreted
Neutralizing antibodies to IL-8, G-CSF, MCP-1, GM-CSF, TGF-␤ , and regulated on activation, normal T-cell ex-pressed and secreted (RANTES) (Genzyme, Cambridge, MA) were added to the HLF supernatant fluids that were harvested at 72 h after exposure to 100 M of BK at the concentrations recommended for inhibiting these cytokines, and the resulting preparations were incubated for 30 min at 37 Њ C. The antibodies to IL-8, G-CSF, MCP-1, GM-CSF, TGF-␤ , and RANTES were tested by blockade of the chemotactic response of neutrophils and monocytes to each human recombinant cytokine. The HLF samples containing the antibodies were then used for chemotactic assay. The antibodies did not influence the chemotactic response to endotoxin-activated serum (data not shown). To assess the nonspecific effect of immunoglobulin (Ig)G, nonimmune IgG (Genzyme) was added to the supernatant fluids, incubated for 30 min at 37 Њ C, and used for chemotactic assay.
Measurement of IL-8, G-CSF, MCP-1, GM-CSF, TGF-␤ , and RANTES
The concentrations of IL-8, G-CSF, MCP-1, GM-CSF, TGF-␤, and RANTES in HLF supernatant fluids cultured for 72 h at the BK concentration of 100 M were measured with enzyme linked immunosorbent assays (ELISAs) according to the manufacturers' directions. Assay kits for GM-CSF and RANTES were purchased from Amersham (Buckinghamshire, UK), and the minimum concentrations detected with these assays were 2.0 pg/ml for GM-CSF, and 15.6 pg/ml for RANTES. IL-8, MCP-1, and TGF-␤ kits were purchased from R&D Systems (Minneapolis, MN), and the minimum detectable concentration of IL-8, MCP-1, and TGF-␤ was 10.0 pg/ml, 31.3 pg/ml, and 0.31 ng/ml, respectively. A chemiluminescence enzyme immunoassay (CLEIA) assay kit for G-CSF was obtained from Chugai Pharmaceutical Co. (Tokyo, Japan), with a minimum detectable G-CSF concentration of 1.0 pg/ml.
Statistics
In experiments in which multiple measurements were made, differences between groups were tested for significance through one-way analysis of variance, with Fisher's multiple-range test applied to data at specific times and dose points. In experiments in which single measurements were made, differences between groups were tested for significance through Student's paired t test. In all cases, a value of P Ͻ 0.05 was considered significant. Data in figures and tables are expressed as mean Ϯ SE.
Results
Concentrations of BK in HLF Cultures
BK at the initial concentration of 50 g/ml declined to 1.32 Ϯ 0.01 g/ml at 12 h, to 0.00523 Ϯ 0.000112 g/ml at 24 h, and to 0.000101 Ϯ 0.000009 g/ml at 48 h, becoming undetectable at 72 h (n ϭ 3 monolayers). Thus, the half-life of BK was less than 12 h, and very litle BK was present in the supernatant fluid after 72 h. Because most of the BK in the supernatant fluids was metabolized by 72 h, the exposure of HLF to BK was observed after 96 h.
Release of NCA and MCA from HLF HLF released NCA and MCA in a dose-dependent manner in response to BK ( Figures 1A and 1B) . The lowest doses of BK that stimulated HLF were 0.1 M for neutrophils and 0.01 g/ml for monocytes. Increasing concentrations of BK, to 100 M, progressively increased the release of NCA and MCA. Although HLF released NCA and MCA constitutively, HLF further released NCA and MCA in response to BK in a time-dependent manner (Figures 2A and 2B ). The release of NCA and MCA was significant after 24 h exposure to BK (Figures 2A and 2B) . The release of chemotactic activity reached a plateau at 72 h. BK itself did not show any chemotactic activity for either neutrophils or monocytes (data not shown). The chemotactic responses to LTB 4 and to formyl-methionyl-leucylphenylalanine (FMLP) as a positive control at a concentration of 10 Ϫ7 M for each were 102.0 Ϯ 7.4 and 118.5 Ϯ 8.9 cells/hpf, respectively, for neutrophils, and 75.6 Ϯ 3.4 and 84.3 Ϯ 7.8 cells/hpf, respectively, for monocytes. The chemotactic responses to normal saline as a negative control were 10.5 Ϯ 2.7 cells/hpf for neutrophils and 7.3 Ϯ 1.8 cells/hpf for monocytes.
Checkerboard analysis revealed that the HLF supernatant fluids to which BK was added induced neutrophil migration in the presence of a gradient across the membrane in a concentration-dependent manner (data not shown). The passage of neutrophils was therefore consistent with chemotactic rather than with chemokinetic migration. In contrast, monocyte migration was induced only slightly in the absence of a gradient (data not shown), indicating that it was predominantly chemotactic and partly chemokinetic.
Confirmation that the cells that had migrated were monocytes was provided by the findings that: (1) Ͼ 90% of the cells that migrated appeared to be monocytes morphologically by light microscopy; (2) Ͼ 90% of the cells that migrated were esterase positive; and (3) lymphocytes purified by allowing the monocytes to attach to plastic, and tested in the chemotaxis assay, showed only 0-20% of the chemotactic activity of the monocyte preparation.
Inhibition of the Release of Chemotactic Activity by Metabolic Inhibitors
The supernatant fluids incubated with 100 M BK in the presence of NDGA, DEC, and AA-861 showed a decrease in the release of NCA and MCA (P Ͻ 0.001; Figures 3A  and 3B) . Cycloheximide inhibited the release of both NCA (P Ͻ 0.001; Figure 3A ) and MCA (P Ͻ 0.001; Figure 3B ).
Molecular Sieve Column-Chromatographic Findings for Released Chemotactic Activities
Molecular sieve column chromatography with Sephadex G-100 revealed that NCA was heterogeneous in size (Figure 4A) . At least three peaks of NCA were separated by column chromatography, with estimated molecular weights above and below that of cytochrome C (MW: 12,300 D) and an additional peak that eluted after quinacrine (MW: 450 D). The released MCA was also heterogeneous (Figure 4B) . At least four peaks of MCA appeared to be separated by column chromatography, with estimated molecular weights below those of BSA and cytochrome C, and an additional peak that eluted after quinacrine.
Inhibition of NCA and MCA by LTB 4 Receptor Antagonists Both the NCA and MCA of crude samples were significantly inhibited by addition of the LTB 4 receptor antagonist ONO 4057, by about 70% for NCA and 40% for MCA (P Ͻ 0.001; Figures 5A and 5B) . ONO 4057 also inhibited the column chromatographically separated lowestmolecular-weight peaks of NCA and MCA (by about 80% for NCA and 60% for MCA). In contrast, PAF receptor antagonist had no effects on NCA or MCA. LTB 4 and PAF receptor antagonists, each at a concentration of 10 Ϫ5 M, completely inhibited neutrophil migration in response to a 10 Ϫ7 M concentration of LTB 4 and PAF, but showed no inhibitory effects on FMLP-or endotoxin-activated serum-induced neutrophil and monocyte chemotaxis (data not shown). 
Release of LTB 4 from HLF
The measurement of LTB 4 in supernatant fluids with RIA revealed that HLF released a significant quantity of LTB 4 in the baseline culture condition. However, the addition of BK at a concentration of 100 M for 72 h did not induce LTB 4 release from HLF (244 Ϯ 20 pg/ml [control] versus 254 Ϯ 9 pg/ml [BK]; P ϭ 0.10). PAF was not detected in the baseline or BK-stimulated supernatant fluids (i.e., was present at less than 40 pg/ml).
Inhibition of NCA and MCA by Polyclonal Antibodies to IL-8, G-CSF, MCP-1, GM-CSF, TGF-␤, and RANTES
Because HLF had the potential to release chemokines, and because chemokines released from HLF might be responsible for NCA and MCA, we used polyclonal blocking antibodies to IL-8, G-CSF, MCP-1, GM-CSF, TGF-␤, and RANTES to study release of these chemokines. Among these antibodies, antibodies to IL-8 and G-CSF inhibited NCA (P Ͻ 0.01; Figure 6A ). Antibodies to MCP-1 and GM-CSF inhibited MCA (P Ͻ 0.01; Figure 6B ). Anti-TGF-␤ antibody slightly but significantly attenuated MCA (P Ͻ 0.05; Figure 6B ). In contrast, antibody to RANTES did not inhibit MCA. We evaluated the effect of antibodies to IL-8, G-CSF, MCP-1, GM-CSF, and TGF-␤ on column chromatographically separated NCA and MCA. These antibodies also inhibited NCA and MCA at molecular weights corresponding to the respective chemotactic peaks by about 60-80%.
Release of IL-8, MCP-1, G-CSF, GM-CSF, TGF-␤, and RANTES from HLF by BK
Measurement of chemotactic cytokines through ELISA revealed that BK at a concentration of 100 M, following 72 h incubation, stimulated the release of IL-8 and G-CSF as NCA (P Ͻ 0.001; Table 1 ) and of GM-CSF, MCP-1, and TGF-␤ as MCA (P Ͻ 0.05; Table 1 ). In contrast, RANTES was not detected in HLF supernatant fluids.
Because NCA comprised IL-8 and G-CSF, and because MCA comprised MCP-1 and GM-CSF, we evaluated the individual time course of mediators that exhibited chemotactic activity (Figures 7A throught 7D) . All chemokines showed time-dependent increases in concentration.
Inhibition of Release of NCA, MCA, and Individual Chemokines by Both BKB 1 and BKB 2 Receptor Antagonists Both BKB 1 and BKB 2 receptor antagonists significantly inhibited the release of NCA and MCA harvested in both cases after 72 h incubation ( Figures 8A and 8B) . The individual chemokines (i.e., IL-8, G-CSF, MCP-1, and GM-CSF) were significantly inhibited by BKB 1 and BKB 2 receptor antagonists (Figures 9A through 9D ).
Discussion
BK is thought to be a potent inflammatory mediator in lung disease (26, 27) . Turino and coworkers suggested that immunoreactive kinins and kininogenase activity were present in bronchoalveolar lavage fluid and plasma obtained from patients with lung inflammation (27) . BK is generated from kininogens by the action of plasma and tissue kallikreins (26, 27) , and its action includes vasodilation, vascular leakage, and contraction of smooth muscle (24, 27) . BK has also been found to stimulate alveolar and bronchial epithelial cells and AM to release NCA and MCA (28, 29) . In the present study, BK induced the release of NCA and MCA from HLF, which may contribute to inflammatory cell extravasation from the vasculature to the interstitium. Definition of abbreviations: G-CSF ϭ granulocyte colony-stimulating factor; GM-CSF ϭ granulocyte-macrophage colony-stimulating factor; MCP-1 ϭ monocyte chemoattractant protein-1; ND ϭ not detected; RANTES ϭ regulated on activation, normal T cells expressed and secreted; TGF-␤ ϭ transforming growth factor-␤.
*P Ͻ 0.05 compared with control. † P Ͻ 0.01 compared with control. ‡ P Ͻ 0.001 compared with control. Although the potential of HLF to release IL-8, G-CSF, GM-CSF, MCP-1, and TGF-␤ in response to BK was less than that observed upon stimulation of HLF with TNF-␣ and IL-1␤ (data not shown), the release of NCA and MCA was increased by 3-to 4-fold compared with the constitutive release of chemotactic activity. The chemotactic potential of the activity released from HLF was greater than that released from 10 6 AM per culture dish in response to endotoxin (unpublished data). It is therefore likely that BK contributes to the recruitment of inflammatory cells to the lung interstitium from the vasculature by stimulating HLF.
It has been reported that lung fibroblasts have the potential to release IL-8 and G-CSF in response to TNF-␣ or IL-1␤ (38, 39) . In the present study, blocking antibodies to IL-8 and G-CSF attenuated NCA to a similar level of chemotactic activity. BK stimulated the release of IL-8 and G-CSF from HLF. Although IL-8 is well known as a neutrophil chemotactic factor in a variety of inflammatory diseases, the role of G-CSF in exerting neutrophil chemotactic activity is less certain. In the present study, HLF released G-CSF as NCA in response to both BK and IL-8.
Wang and colleagues (40) reported that the concentration of G-CSF as NCA was 7-70 ng/ml. However, the concentration of G-CSF detected in the HLF supernatant fluids in our study was less than that reported (40) . We produced neutrophil chemotaxis by using human recombinant G-CSF. The chemotactic concentration of G-CSF as NCA ranged from 10 to 100 pg/ml (unpublished data). The variation in the G-CSF concentration as a neutrophil chemotactic factor may have been due to differences in neutrophil separation. Because the blocking antibodies to G-CSF that were used in our study inhibited both total NCA in the supernatant fluids and NCA in the column chromatographically separated peaks, the contribution of G-CSF to NCA may be as a direct chemoattractant rather than through the activation of neutrophils.
The identification of NCA and MCA released from HLF is not complete. However, the inhibition of release of NCA and MCA by cycloheximide treatment suggests that these activities are at least partly dependent on protein synthesis (41) . NCA and MCA were attenuated by antibodies to IL-8, G-CSF, MCP-1, GM-CSF, and TGF-␤. The concentrations of IL-8, G-CSF, MCP-1, GM-CSF, and TGF-␤ in the supernatant fluids reached reported concentrations of NCA and MCA (42) (43) (44) . Accordingly, HLF at least partly released IL-8, G-CSF, MCP-1, GM-CSF, and TGF-␤ in the form of NCA and MCA.
HLF have the potential to release MCP-1, GM-CSF, and TGF-␤. However, the predominant MCA found in our study was in the form of GM-CSF and MCP-1, rather than TGF-␤. The release of GM-CSF from HLF in response to BK was striking compared with its release from alveolar or bronchial epithelial cells (data not shown). Because GM-CSF is one of glycoproteins that can stimulate the in vitro proliferation and differentiation of macrophage progenitor cells (45, 46) , its augmented release from fibroblasts in response to BK suggest that fibroblasts rather than airway epithelial cells may be profoundly involved in macrophage recruitment, differentiation, and proliferation, and in macrophage activation in the lung interstitium.
The inhibition of release of NCA and MCA by NDGA, DEC, and AA-861 suggests that these activities are composed of lipoxygenase products. Both NCA and MCA were inhibited by LTB 4 receptor antagonist. Although the release of LTB 4 from HLF in response to BK was not significant compared with the control value, the concentration of LTB 4 reached the chemotactic range for neutrophils and monocytes. Thus, LTB 4 released constitutively from fibroblasts may be one of the important chemoattractants for neutrophils and monocytes (47) .
BK has been reported to have several potent effects on airway functions, many of which are thought to be mediated by the BKB 2 receptor. (50) . Human lung fibroblasts of the WI-38 cell line express BKB 1 and BKB 2 receptors (39), and BK stimulates NF-kB activation and also induces IL-1␤ mRNA expression via the BKB 2 receptor. IL-1␤ production by BK-stimulated cells may also exert a positive effect on the expression of both BKB 1 and BKB 2 receptors. IL-1␤ is known to be one of the most potent inducing agents for the BKB 1 receptor (51, 52) , and it may also increase the expression of functional BKB 2 receptors (53) (54) (55) . Collectively, these findings suggest that both BKB 1 and BKB 2 receptors were involved in the release of NCA and MCA and of individual chemokines (i.e., IL-8, G-CSF, GM-CSF, and MCP-1) in the present study.
Although TGF-␤ was detected in HLF supernatant fluid, antibody to TGF-␤ did not attenuate MCA in our study. TGF-␤ induces monocyte chemotaxis at concentrations of 0.1-10 pg/ml (43) . At higher concentrations of TGF-␤, the chemotactic response of monocytes declines. It has been reported that the biologically inactive form of TGF-␤, which constitutes more than 98% of autocrine TGF-␤, is secreted by 12 different cell types (56) . It was also found that TGF-␤ was unable to bind to its receptor without prior proteolytic activation (56) . The release of inactive TGF-␤ may account for the failure of anti-TGF-␤ antibody to inhibit MCA in the HLF supernatant fluids in our study.
In conclusion, we found that BK stimulated HLF to release NCA and MCA. The NCA and MCA released in response to BK included IL-8, G-CSF, MCP-1, GM-CSF, TGF-␤, and LTB 4 . These results suggest that BK may play a role in inflammatory cell recruitment from the vasculature to the interstitium by stimulating the release of chemotactic activity from lung fibroblasts.
